<p><strong><em>续签 Aetna Signature Administrator 网络协议，并通过 Faircost Optimizer 增强成本控制</em></strong></p>
<p>, /PRNewswire/ -- Marpai, Inc.（&#34;Marpai&#34;或&#34;公司&#34;）（OTCQX: MRAI），一家创新医疗技术、药房福利管理（PBM）和第三方管理（TPA）服务的领导者，宣布在新年到来之际取得了显著的积极势头，2026 年的销售周期超出预期，并续签了与 Aetna 的关键网络接入协议。</p>
<p>公司报告了强劲的销售周期，确保了 2026 年 1 月 1 日的新客户数量超出内部预期，进一步巩固了其可扩展增长的道路和之前指导的盈利目标。</p>
<p>作为巩固其顶级网络服务的一项举措，Marpai 成功续签了对 Aetna Signature Administrator（ASA）PPO 网络的接入协议。此项续签确保 Marpai 的自筹资金雇主客户及其成员继续获得对 Aetna 广泛的高质量提供者网络的全国性接入，保持护理的连续性和竞争性的网络折扣。</p>
<p>此外，Marpai 现在将提供 Aetna Faircost Optimizer 作为福利计划管理员的集成成本管理工具。Faircost Optimizer 旨在帮助计划赞助商有效管理其网络外索赔成本，这些成本往往不可预测且难以控制。通过利用这一复杂工具，Marpai 增强了其提供卓越成本控制的能力，为非合同索赔提供最大节省，并保护自筹资金计划免受过高的余额账单影响。</p>
<p>Marpai 首席执行官 Damien Lamendola 表示：&#34;我们将创新技术与一流网络接入相结合的战略在市场上显然得到了积极响应。2026 年销售周期的成功，加上 Aetna Signature Administrator 网络协议的重要续签，为未来一年奠定了坚实的基础。Aetna 的 Faircost Optimizer 的加入改变了我们的产品，为客户提供了一个强大的杠杆，以削减网络外责任并推动显著的计划节省。&#34;</p>
<p><strong>关于 Marpai, Inc.</strong></p>
<p>Marpai, Inc.（OTCQX: MRAI）是一家技术平台公司，运营子公司，向直接支付员工健康福利的雇主提供 TPA、PBM 和价值导向的健康计划服务。主要在 1500 亿美元的 TPA 行业竞争，服务于自筹资金的雇主健康计划，代表超过 1.5 万亿美元的年度索赔。通过其 <strong><em>Marpai Saves</em></strong> 计划，公司致力于为健康计划预算提供最健康的成员群体。Marpai 在全国范围内运营，提供对包括 Aetna 和 Cigna 在内的领先提供者网络的接入以及所有 TPA 服务。有关更多信息，请访问 www.marpaihealth.com，内容不包含在本新闻稿中。投资者可访问 https://ir.marpaihealth.com。</p>
<p><strong>前瞻性声明免责声明</strong></p>
<p>本新闻稿包含前瞻性声明，按照 1995 年私人诉讼改革法案的定义，涉及重大风险和不确定性。前瞻性声明可以通过使用诸如&#34;预期&#34;、&#34;期望&#34;、&#34;意图&#34;、&#34;计划&#34;、&#34;相信&#34;、&#34;寻求&#34;、&#34;估计&#34;、&#34;指导&#34;、&#34;可能&#34;、&#34;可以&#34;、&#34;将&#34;、&#34;潜在&#34;、&#34;应该&#34;、&#34;目标&#34;及这些词或类似表达的变体来识别。例如，公司在讨论 2026 年第一季度的当前销售率以及 Aetna Signature Network 和 Faircost Optimizer 计划的影响时使用了前瞻性声明。读者被警告不要对这些前瞻性声明过于依赖，这些声明反映了 Marpai 当前的期望，仅在本发布之日有效。实际结果可能因多种因素而与 Marpai 当前的期望大相径庭。这些因素包括但不限于一般经济和市场条件的不利变化、竞争因素（包括但不限于价格压力和新产品推出）、客户对新产品的接受不确定性和市场变化、管理业务增长的风险。除法律要求外，Marpai 不承担任何责任来修订或更新任何前瞻性声明，无论是由于新信息、未来事件还是其他原因。</p>
<p>有关 Marpai 及可能影响前瞻性声明实现的风险因素的更详细信息，请参阅 Marpai 向证券交易委员会提交的文件。投资者和证券持有人被敦促在 SEC 网站 http://www.sec.gov 上免费阅读这些文件。</p>
<p>来源 Marpai</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjAxJk5ld3NJdGVtSWQ9TlkzNjQ0MSZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDExNjA0UFJfTkVXU19VU1BSX19fX19OWTM2NDQx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjAxJk5ld3NJdGVtSWQ9TlkzNjQ0MSZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDExNjA0UFJfTkVXU19VU1BSX19fX19OWTM2NDQx"/></p>

MRAI

<p>Marpai, Inc.（OTCQX: MRAI）宣布 2026 年将迎来积极的发展势头，销售周期好于预期，并与 Aetna 续签了网络接入协议。该续签确保了对 Aetna 网络的广泛访问，并引入了 Aetna Faircost Optimizer 用于成本管理。首席执行官 Damien Lamendola 强调了他们将创新技术与网络接入相结合的战略成功</p>

<p><strong><em>Renews Aetna Signature Administrator Network Agreement and Enhances Cost Containment with Faircost Optimizer</em></strong></p>
<div class="lb-trans"><p><strong><em>续签 Aetna Signature Administrator 网络协议，并通过 Faircost Optimizer 增强成本控制</em></strong></p>
</div><p>, /PRNewswire/ -- Marpai, Inc. (&#34;Marpai&#34; or the &#34;Company&#34;) (OTCQX: MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced significant positive momentum heading into the new year, highlighted by a better-than-expected sales cycle for 2026 and the renewal of its critical network access agreement with Aetna.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Marpai, Inc.（&#34;Marpai&#34;或&#34;公司&#34;）（OTCQX: MRAI），一家创新医疗技术、药房福利管理（PBM）和第三方管理（TPA）服务的领导者，宣布在新年到来之际取得了显著的积极势头，2026 年的销售周期超出预期，并续签了与 Aetna 的关键网络接入协议。</p>
</div><p>The Company reports a robust sales cycle, securing a volume of new clients for January 1, 2026, that surpasses internal expectations, reinforcing its path to scalable growth and previously guided profitability targets.</p>
<div class="lb-trans"><p>公司报告了强劲的销售周期，确保了 2026 年 1 月 1 日的新客户数量超出内部预期，进一步巩固了其可扩展增长的道路和之前指导的盈利目标。</p>
</div><p>In a move that solidifies its premier network offering, Marpai has successfully renewed its agreement to access the Aetna Signature Administrator (ASA) PPO network. This renewal ensures that Marpai's self-funded employer clients and their members continue to receive broad, national access to Aetna's extensive network of high-quality providers, maintaining continuity of care and competitive network discounts.</p>
<div class="lb-trans"><p>作为巩固其顶级网络服务的一项举措，Marpai 成功续签了对 Aetna Signature Administrator（ASA）PPO 网络的接入协议。此项续签确保 Marpai 的自筹资金雇主客户及其成员继续获得对 Aetna 广泛的高质量提供者网络的全国性接入，保持护理的连续性和竞争性的网络折扣。</p>
</div><p>Furthermore, Marpai will now offer the Aetna Faircost Optimizer as an integrated cost management tool for benefit plan administrators. The Faircost Optimizer is designed to help plan sponsors effectively manage their out-of-network claims costs, which are often unpredictable and challenging to control. By leveraging this sophisticated tool, Marpai enhances its ability to deliver superior cost containment, providing maximum savings on non-contracted claims and protecting self-funded plans from excessive balance billing.</p>
<div class="lb-trans"><p>此外，Marpai 现在将提供 Aetna Faircost Optimizer 作为福利计划管理员的集成成本管理工具。Faircost Optimizer 旨在帮助计划赞助商有效管理其网络外索赔成本，这些成本往往不可预测且难以控制。通过利用这一复杂工具，Marpai 增强了其提供卓越成本控制的能力，为非合同索赔提供最大节省，并保护自筹资金计划免受过高的余额账单影响。</p>
</div><p>Damien Lamendola, Chief Executive Officer of Marpai, stated, &#34;Our strategy of combining innovative technology with best-in-class network access is clearly resonating in the market. The success of our 2026 sales cycle, coupled with the important renewal of the Aetna Signature Administrator network agreement, sets a strong foundation for the year ahead. The addition of Aetna's Faircost Optimizer transforms our offering, handing clients a powerful lever to slash out-of-network liabilities and drive significant plan savings.&#34;</p>
<div class="lb-trans"><p>Marpai 首席执行官 Damien Lamendola 表示：&#34;我们将创新技术与一流网络接入相结合的战略在市场上显然得到了积极响应。2026 年销售周期的成功，加上 Aetna Signature Administrator 网络协议的重要续签，为未来一年奠定了坚实的基础。Aetna 的 Faircost Optimizer 的加入改变了我们的产品，为客户提供了一个强大的杠杆，以削减网络外责任并推动显著的计划节省。&#34;</p>
</div><p><strong>About Marpai, Inc.</strong></p>
<div class="lb-trans"><p><strong>关于 Marpai, Inc.</strong></p>
</div><p>Marpai, Inc. (OTCQX: MRAI) is a technology platform company which operates subsidiaries that provide TPA, PBM and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the $150 billion TPA sector serving self-funded employer health plans representing over $1.5 trillion in annual claims. Through its <strong><em>Marpai Saves</em></strong> initiative, the Company works to deliver the healthiest member population for the health plan budget. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna and all TPA services. For more information, visit www.marpaihealth.com, the content of which is not incorporated by reference into this press release. Investors are invited to visit https://ir.marpaihealth.com.</p>
<div class="lb-trans"><p>Marpai, Inc.（OTCQX: MRAI）是一家技术平台公司，运营子公司，向直接支付员工健康福利的雇主提供 TPA、PBM 和价值导向的健康计划服务。主要在 1500 亿美元的 TPA 行业竞争，服务于自筹资金的雇主健康计划，代表超过 1.5 万亿美元的年度索赔。通过其 <strong><em>Marpai Saves</em></strong> 计划，公司致力于为健康计划预算提供最健康的成员群体。Marpai 在全国范围内运营，提供对包括 Aetna 和 Cigna 在内的领先提供者网络的接入以及所有 TPA 服务。有关更多信息，请访问 www.marpaihealth.com，内容不包含在本新闻稿中。投资者可访问 https://ir.marpaihealth.com。</p>
</div><p><strong>Forward-Looking Statement Disclaimer</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明免责声明</strong></p>
</div><p>This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as &#34;anticipates,&#34; &#34;expects,&#34; &#34;intends,&#34; &#34;plans,&#34; &#34;believes,&#34; &#34;seeks,&#34; &#34;estimates,&#34; &#34;guidance,&#34; &#34;may,&#34; &#34;can,&#34; &#34;could&#34;, &#34;will&#34;, &#34;potential&#34;, &#34;should,&#34; &#34;goal&#34; and variations of these words or similar expressions. For example, the Company is using forward-looking statements when it discusses the current sales rate for Q1 2026 and the impact of the Aetna Signature Network and Faircost Optimizer program. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai's current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.</p>
<div class="lb-trans"><p>本新闻稿包含前瞻性声明，按照 1995 年私人诉讼改革法案的定义，涉及重大风险和不确定性。前瞻性声明可以通过使用诸如&#34;预期&#34;、&#34;期望&#34;、&#34;意图&#34;、&#34;计划&#34;、&#34;相信&#34;、&#34;寻求&#34;、&#34;估计&#34;、&#34;指导&#34;、&#34;可能&#34;、&#34;可以&#34;、&#34;将&#34;、&#34;潜在&#34;、&#34;应该&#34;、&#34;目标&#34;及这些词或类似表达的变体来识别。例如，公司在讨论 2026 年第一季度的当前销售率以及 Aetna Signature Network 和 Faircost Optimizer 计划的影响时使用了前瞻性声明。读者被警告不要对这些前瞻性声明过于依赖，这些声明反映了 Marpai 当前的期望，仅在本发布之日有效。实际结果可能因多种因素而与 Marpai 当前的期望大相径庭。这些因素包括但不限于一般经济和市场条件的不利变化、竞争因素（包括但不限于价格压力和新产品推出）、客户对新产品的接受不确定性和市场变化、管理业务增长的风险。除法律要求外，Marpai 不承担任何责任来修订或更新任何前瞻性声明，无论是由于新信息、未来事件还是其他原因。</p>
</div><p>More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.</p>
<div class="lb-trans"><p>有关 Marpai 及可能影响前瞻性声明实现的风险因素的更详细信息，请参阅 Marpai 向证券交易委员会提交的文件。投资者和证券持有人被敦促在 SEC 网站 http://www.sec.gov 上免费阅读这些文件。</p>
</div><p>SOURCE Marpai</p>
<div class="lb-trans"><p>来源 Marpai</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjAxJk5ld3NJdGVtSWQ9TlkzNjQ0MSZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMDExNjA0UFJfTkVXU19VU1BSX19fX19OWTM2NDQx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY36441&amp;Transmission_Id=202512011604PR_NEWS_USPR_____NY36441&amp;DateId=20251201"/></p>

Marpai 宣布 2026 年的发展势头以及关键合作伙伴的扩展